Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Italy: number of clinical trials authorized for rare diseases 2017, by phase

Number of clinical trials aiming at treating rare diseases in Italy 2017, by phase

by Statista Research Department, last edited Sep 6, 2018
Italy: number of clinical trials authorized for rare diseases 2017, by phase This statistic illustrates the number of clinical trials aiming at treating rare diseases, authorized in Italy in 2017, by phase. According to data, most of the clinical trials approved belonged to phase II and phase III. An average number of the trials authorized were in phase I, while only a minimal part of them were in phase IV.
Show more

Number of clinical trials aiming at treating rare diseases in Italy 2017, by phase

Number of clinical trials
--
--
--
--
Number of clinical trials
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

Download Settings Share
Download started
Please be patient - this may take a moment
by Statista Research Department, last edited Sep 6, 2018
This statistic illustrates the number of clinical trials aiming at treating rare diseases, authorized in Italy in 2017, by phase. According to data, most of the clinical trials approved belonged to phase II and phase III. An average number of the trials authorized were in phase I, while only a minimal part of them were in phase IV.
Show more
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Pharmaceutical industry in Italy
Pharmaceutical industry in Italy

All Information
in one Presentation

Pharmaceutical industry in Italy

Everything On "Pharmaceutical industry in Italy" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Pharmaceutical industry in Italy"
  • Industry overview
  • Key players
  • International trade
  • Research and development
The most important statistics
  • CDMO
  • Forecasts
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.